Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/44003
Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
The complement system is a major effector of innate immunity that has been involved in stroke brain damage. Complement activation occurs through the classical, alternative and lectin pathways. The latter is initiated by mannose-binding lectin (MBL) and MBL-associated serine proteases (MASPs). Here we investigated whether the lectin pathway contributes to stroke outcome in mice and humans.
Subject (English)
Citation
Collections
Citation
CERVERA ÁLVAREZ, Álvaro, et al. Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One. 2010. Vol. 5, num. 2, pags. e8433. ISSN 1932-6203. [consulted: 12 of June of 2026]. Available at: https://hdl.handle.net/2445/44003